Authors: Safra, T Groshen, S Jeffers, S Tsao-Wei, DD Zhou, LY Muderspach, L Roman, L Morrow, CP Burnett, A Muggia, FM

Citation: T. Safra et al., Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin - Analysis of toxicities and predictors of outcome, CANC CYTOP, 91(1), 2001, pp. 90-100

Authors: Safra, T Groshen, S Jeffers, S Tsao-Wei, DD Zhou, LY Muderspach, L Roman, L Morrow, CP Burnett, A Muggia, FM

Citation: T. Safra et al., Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin - Analysis of toxicities and predictors of outcome, CANCER, 91(1), 2001, pp. 90-100

Authors: Morrow, CP

Citation: Cp. Morrow, An opinion in support of second-look surgery in ovarian cancer, GYNECOL ONC, 79(3), 2000, pp. 341-343

Authors: Burnett, AF Coe, FL Klement, V O'Meara, AT Muderspach, LI Roman, LD Morrow, CP

Citation: Af. Burnett et al., The use of a pelvic displacement prosthesis to exclude the small intestinefrom the radiation field following radical hysterectomy, GYNECOL ONC, 79(3), 2000, pp. 438-443

Authors: Burnett, AF Roman, LD Garcia, AA Muderspach, LI Brader, KR Morrow, CP

Citation: Af. Burnett et al., A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix, GYNECOL ONC, 76(1), 2000, pp. 63-66